DGAP-News: curasan AG: curasan AG postpones annual financial report 2019 to 31 July 2020
Numerous patents and a broad record of scientific publications demonstrate the clinical success of the products and the highly innovative strength of curasan.
DGAP-News: curasan AG / Key word(s): Annual Results curasan AG: curasan AG postpones annual financial report 2019 to 31 July 2020 30.06.2020 / 16:10 The issuer is solely responsible for the content of this announcement. curasan AG: curasan AG postpones annual financial report 2019 to 31 July 2020 Kleinostheim, Germany, 30 June 2020 - The Management Board of curasan AG (shares: ISIN DE000A2YPGM4 / convertible bond: ISIN DE000A2TR497) announces that the publication of the annual financial report 2019, originally planned for 30 June 2020, will be postponed to 31 July 2020. The reason for the delay is that the binding offer submitted by Donau Invest Beteiligungsges. m.b.H., Vienna, which is to be implemented in the insolvency plan, still has to be examined by the auditor with regard to the continuation prognosis.
30.06.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | curasan AG |
Lindigstraße 4 | |
63801 Kleinostheim | |
Germany | |
Phone: | 06027/40 900 0 |
Fax: | 06027/40 900 29 |
E-mail: | [email protected] |
Internet: | www.curasan.de |
ISIN: | DE000A2YPGM4 |
WKN: | A2YPGM |
Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1082855 |
End of News | DGAP News Service |
|
1082855 30.06.2020